TVTX

Travere Therapeutics, Inc.NASDAQHealthcare

$30.44-3.12%ClosedMarket Cap: $2.81B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-25	JP Morgan	—	Overweight	—
2026-02-06	Piper Sandler	—	Neutral	—
2025-11-28	HC Wainwright & Co.	—	Buy	—
2025-11-04	Piper Sandler	—	Neutral	—
2025-10-31	TD Cowen	—	Buy	—
2025-09-19	HC Wainwright & Co.	—	Buy	—
2025-09-12	Stifel	—	Hold	—
2025-09-11	Wells Fargo	—	Overweight	—
2025-08-07	Wedbush	—	Outperform	—
2025-08-07	Scotiabank	—	Sector Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$2.17	$926.9M	8
Sun Dec 31	$3.41	$1.09B	6
Mon Dec 31	$4.07	$1.31B	4
Tue Dec 31	$5.07	$1.52B	2